Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_assertion type Assertion NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_head.
- NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_assertion description "[Aberrant methylation of TFPI-2 was also detected in 73% (102/140) of pancreatic cancer xenografts and primary pancreatic adenocarcinomas, was more likely in older patients with pancreatic cancer, and significantly correlated with progression of IPMNs (P=0.0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_provenance.
- NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_assertion evidence source_evidence_literature NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_provenance.
- NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_assertion SIO_000772 15592528 NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_provenance.
- NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_assertion wasDerivedFrom befree-20140225 NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_provenance.
- NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_assertion wasGeneratedBy ECO_0000203 NP673676.RAJXjbe18KCFGf09pUXN3GV1I8CwLh7j2D-RRyuH3Ijj0130_provenance.